Skip to main content
Center for Integration of Science and Industry

Center for Integration of Science and Industry

" "

MISSION

The mission of the Center for Integration of Science and Industry is to "understand the process by which science is translated for public value, and accelerate this translation by engaging science and industry in interdisciplinary dialogue, scholarship, and education."

The Center brings together the perspectives of natural science, business, analytics, and policy to understand, and advance, the path of translational science and the business models that create public value from the fruits of scientific discovery.

Bentley's Center for Integration of Science and Industry is pretty unique. It's a research center at a school that has both a great business tradition and a great science department and our role is really to try to bring that together."

- Dr. Fred Ledley, Director, Center for Integration of Science and Industry

Research & News

Alexandria Ocasio-Cortez Stands Up to Big Pharma

Representative Alexandria Ocasio-Cortz uses information from the Center for Integration of Science and Industry's PNAS paper to build a case around "... your tax dollars are helping big pharmaceutical companies get rich ..." [...]

Learn More

Representation of Industry in Introductory Biology Textbooks: A Missed Opportunity to Advance STEM Learning

The majority of students who enroll in undergraduate biology courses will eventually be employed in non-STEM (science, technology, engineering, and mathematics) business occupations. This work explores how representations of industry in undergraduate biology textbooks could impact STEM learning for these students and their ability to apply this learning in their chosen work.

Learn More

Bentley University study shows NIH spent more than $100 billion on basic science for new medicines

The new report from the Center for Integration of Science and Industry at Bentley University, published in the Proceedings of the National Academy of Sciences, shows that the United States government invested more than $100 billion in the basic research that led to new medicines approved by the Food and Drug Administration (FDA) between 2010 and 2016.

Learn More
Research Highlights
Almetric 20180805

Contribution of NIH funding to new drug approvals 2010–2016

View continuously updated attention metrics for article published in Proceedings of the National Academy of Sciences of the United States of America, February 2018.

 

Learn More

Data Visualization

The chart highlights over 2 million research publications referencing the 210 drugs approved 2010-2016 or their biological targets. The majority of the publications are on the target, exemplifying basic science without a specific product in mind. Research into the target typically spans decades before the drug is developed and later approved by the FDA. 30% of these research publications were supported by NIH funding, totaling >$100B over the span of 16 years.

Drug Target Pubs Motion Chart
Student Alumni Spotlight
Aaron Perlman, '13

Aaron Perlman, '13

"I had the privilege of watching the Center for Integration of Science and Industry grow from an unnamed group of a few passionate professors and their trusty research assistants into a fully established research facility. My journey with started in 2011 when I began working with Dr. Ledley on a project to determine the effectiveness of cancer research and drug development since the War on Cancer was declared in 1971. ... "

Read More